![]() |
|
|
Drug Metabolism and Pharmacokinetics Department, Novartis
Pharmaceuticals Corporation
The metabolic pathways of clozapine (CZ, Clozaril
(Novartis Pharmaceuticals Corporation, East Hanover, NJ),
8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine, a tricylic benzodiazepine neuroleptic which has a reduced risk of
unwanted neurological effects, were determined in normal male volunteers after a single oral dose of 50 mg of
[14C]CZ. There was no
radioactivity in exhaled breath, and excretion of total radioactivity
was approximately 50% in urine and 30% in feces; parent
CZ was a minor component in the excreta. The metabolic
profiles were determined in urine and feces using HPLC coupled with
radioactivity monitoring. The major metabolic pathways were
demethylation, oxidation of the aromatic ring in the 7- and 8-positions, and conjugation. The major urinary components were 8-hydroxy-deschloro-DCZ (desmethylCZ) and its
glucuronide, 7-hydroxy-8-chloro-DCZ sulfate and
CZ-NO (clozapine N-oxide). Minor amounts of
CZ, 7-hydroxy-8-chloro-CZ glucuronide and
DCZ were also present. In feces the major component was
CZ-N-glucuronide. Urinary excretion of
CZ-NO was more rapid than the products of aromatic ring
hydroxylation and conjugation.
This article has been cited by other articles:
![]() |
R. S. Obach, R. L. Walsky, K. Venkatakrishnan, E. A. Gaman, J. B. Houston, and L. M. Tremaine The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 336 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mori, Y. Maruo, M. Iwai, H. Sato, and Y. Takeuchi UDP-GLUCURONOSYLTRANSFERASE 1A4 POLYMORPHISMS IN A JAPANESE POPULATION AND KINETICS OF CLOZAPINE GLUCURONIDATION Drug Metab. Dispos., May 1, 2005; 33(5): 672 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Breyer-Pfaff and H. Wachsmuth Tertiary N-Glucuronides of Clozapine and Its Metabolite Desmethylclozapine in Patient Urine Drug Metab. Dispos., October 1, 2001; 29(10): 1343 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schaber, G. Wiatr, H. Wachsmuth, M. Dachtler, K. Albert, I. Gaertner, and U. Breyer-Pfaff Isolation and Identification of Clozapine Metabolites in Patient Urine Drug Metab. Dispos., June 1, 2001; 29(6): 923 - 931. [Abstract] [Full Text] |
||||
![]() |
U. Mey, H. Wachsmuth, and U. Breyer-Pfaff Conjugation of the Enantiomers of Ketotifen to Four Isomeric Quaternary Ammonium Glucuronides in Humans In Vivo and in Liver Microsomes Drug Metab. Dispos., November 1, 1999; 27(11): 1281 - 1292. [Abstract] [Full Text] |
||||